Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 2
This trial is for women with ovarian cancer that has come back (recurrent cancer) after having surgery and platinum chemotherapy. Platinum chemotherapy includes the drugs cisplatin, carboplatin and oxaliplatin.
It is for women who have:
These cancers are treated in the same way, so when we use the term ovarian cancer in this summary, we are referring to all three.
Recruitment start: 27 May 2016
Recruitment end: 8 September 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jonathan Ledermann
Merck Sharp & Dohme Ltd
Last reviewed: 25 Jan 2017
CRUK internal database number: 14100